Brazil Biopharmaceutical Excipients Market Size & Outlook

The biopharmaceutical excipients market in Brazil is expected to reach a projected revenue of US$ 127.8 million by 2033. A compound annual growth rate of 4.9% is expected of Brazil biopharmaceutical excipients market from 2026 to 2033.
Revenue, 2025 (US$M)
$87.5
Forecast, 2033 (US$M)
$127.8
CAGR, 2026 - 2033
4.9%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil biopharmaceutical excipients market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil biopharmaceutical excipients market highlights

  • The Brazil biopharmaceutical excipients market generated a revenue of USD 87.5 million in 2025 and is expected to reach USD 127.8 million by 2033.
  • The Brazil market is expected to grow at a CAGR of 4.9% from 2026 to 2033.
  • In terms of segment, solubilizes & surfactants/emulsifiers was the largest revenue generating product in 2025.
  • Specialty Excipients is the most lucrative product segment registering the fastest growth during the forecast period.


Biopharmaceutical excipients market data book summary

Market revenue in 2025USD 87.5 million
Market revenue in 2033USD 127.8 million
Growth rate4.9% (CAGR from 2026 to 2033)
Largest segmentSolubilizes & surfactants/emulsifiers
Fastest growing segmentSpecialty Excipients
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSpecialty Excipients, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates
Key market players worldwideMerck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.8% of the global biopharmaceutical excipients market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Latin America, Brazil biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2033.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 24.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceutical Excipients Market Companies

Name Profile # Employees HQ Website
J. Rettenmaier & Söhne View profile 101-250 Holzmühle, Sachsen, Germany, Europe https://www.jrs.eu
DFE Pharma View profile 251-500 Goch, Nordrhein-Westfalen, Germany, Europe https://www.dfepharma.com/
Sigachi View profile 501-1000 Hyderabad, Andhra Pradesh, India, Asia https://sigachi.com
Spectrum Chemical Manufacturingrp View profile 101-250 New Brunswick, New Jersey, United States, North America https://www.spectrumchemical.com
Colorcon View profile 1001-5000 Harleysville, Pennsylvania, United States, North America https://www.colorcon.com
IMCD NV View profile 4948 Wilhelminaplein 32, Rotterdam, Netherlands, 3072 DE https://www.imcdgroup.com
Roquette America View profile 5001-10000 Gurnee, Illinois, United States, North America https://www.roquette.com/
Clariant AG View profile 10481 Rothausstrasse 61, Muttenz, Switzerland, 4132 http://www.clariant.com
Associated British Foods PLC View profile 133000 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY https://www.abf.co.uk
Evonik Industries AG View profile 33409 Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 https://www.evonik.com
Basf SE View profile 111855 Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 https://www.basf.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Brazil biopharmaceutical excipients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.


Solubilizes & surfactants/emulsifiers was the largest segment with a revenue share of 41.26% in 2025. Horizon Databook has segmented the Brazil biopharmaceutical excipients market based on specialty excipients, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2021 to 2033.


A number of initiatives undertaken in Brazil, such as strategic alliances to manage costs along with expansion of local production capacity, are expected to create lucrative growth opportunities for drug manufacturers.

Thus, international drug manufacturers prefer Brazil as a lucrative market for expansion. In addition, Brazilian pharmaceutical industry has witnessed rapid growth since 2004 and is anticipated to do so in the near future.

Reasons to subscribe to Brazil biopharmaceutical excipients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil biopharmaceutical excipients market databook

  • Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biopharmaceutical excipients market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil biopharmaceutical excipients market size, by product, 2021-2033 (US$M)

Brazil Biopharmaceutical Excipients Market Outlook Share, 2025 & 2033 (US$M)

Brazil biopharmaceutical excipients market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online